Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Kane Biotech Inc V.KNE

Alternate Symbol(s):  KNBIF

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.


TSXV:KNE - Post by User

Bullboard Posts
Comment by CurlyMickon May 22, 2014 5:39pm
86 Views
Post# 22589594

RE:RE:RE:RE:T - 13 Days

RE:RE:RE:RE:T - 13 DaysWell you may be right Champ, but you may be wrong too. There is legally nothing stopping a public company from timing an announcement of a material change at an AGM and Special Meeting. Is there? I don't think so and in fact I have seen it many times, intentional and unintentional disclosure of material change at AGMs.

Insofar as the other comments, of course there is a great possibility that KNE will be an ongoing entity researching and seeking opportunities for its products. I'm far from the buyout believer like some others, although that's a possibility too.

Regardless, the DD exercise is done IMHO and we are going to hear news soon about how that will flesh out. I think it will be positive news shared at the AGM in Montreal.

Again, this is only my spec, but...

Do your own DD.


Bullboard Posts